{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:45:39Z","timestamp":1776728739695,"version":"3.51.2"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ijantimicag.2019.06.015","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T07:52:06Z","timestamp":1561017126000},"page":"478-486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Comparison of antibiotic treatment guidelines for urinary tract infections in 15 European countries: Results of an online survey"],"prefix":"10.1016","volume":"54","author":[{"given":"Karin","family":"Malmros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1749-9464","authenticated-orcid":false,"given":"Benedikt D.","family":"Huttner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cliodna","family":"McNulty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Rodr\u00edguez-Ba\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Pulcini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"T\u00e4ngd\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.ijantimicag.2019.06.015_bib0001","first-page":"1","article-title":"Ambulatory medical care utilization estimates for 2007","volume":"169","author":"Schappert","year":"2011","journal-title":"Vital Health Stat"},{"key":"10.1016\/j.ijantimicag.2019.06.015_bib0002","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/519268","article-title":"Population-based epidemiologic analysis of acute pyelonephritis","volume":"45","author":"Czaja","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.06.015_bib0003","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020251","article-title":"Cost of hospitalised patients due to complicated urinary tract infections: a retrospective observational study in countries with high prevalence of multidrug-resistant Gram-negative bacteria: the COMBACTE-MAGNET, RESCUING study","volume":"8","author":"Vallejo-Torres","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijantimicag.2019.06.015_bib0004","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s40261-013-0069-x","article-title":"An economic perspective on urinary tract infection: the 'costs of resignation'","volume":"33","author":"Ciani","year":"2013","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.ijantimicag.2019.06.015_bib0005","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1054\/drup.2000.0167","article-title":"The impact of antibiotic use on resistance development and persistence","volume":"3","author":"Barbosa","year":"2000","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijantimicag.2019.06.015_bib0006","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1128\/AAC.02176-12","article-title":"Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection","volume":"57","author":"Brown","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.06.015_bib0007","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.06.015_bib0008","unstructured":"Grabe M, Bartoletti R, Bjerklund Johansen TE, Cai T, \u00c7ek M, K\u00f6ves B, et al.; European Association of Urology. Guidelines on urological infections 2015. https:\/\/uroweb.org [Accessed 15 December 2018]."},{"key":"10.1016\/j.ijantimicag.2019.06.015_sbref0008","series-title":"Surveillance of antimicrobial resistance in Europe 2017. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2018"},{"key":"10.1016\/j.ijantimicag.2019.06.015_bib0010","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/cid\/cir838","article-title":"Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia","volume":"54","author":"Pulcini","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.06.015_bib0011","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijantimicag.2016.09.029","article-title":"Forgotten antibiotics: a follow-up inventory study in Europe, the USA, Canada and Australia","volume":"49","author":"Pulcini","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.06.015_bib0012","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/archinternmed.2010.482","article-title":"Analysis of overall level of evidence behind Infectious Diseases Society of America practice guidelines","volume":"171","author":"Lee","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ijantimicag.2019.06.015_bib0013","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.cmi.2016.08.015","article-title":"CMI guidance for authors of surveys","volume":"22","author":"Pulcini","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.06.015_bib0014","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.cmi.2017.07.014","article-title":"The methodology of surveillance for antimicrobial resistance and healthcare-associated infections in Europe (SUSPIRE): a systematic review of publicly available information","volume":"24","author":"Nunez-Nunez","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.06.015_bib0015","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/j.1469-0691.2011.03519.x","article-title":"Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting","volume":"17","author":"Kronenberg","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.06.015_bib0016","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijantimicag.2011.09.013","article-title":"Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO\u2022SENS study revisited","volume":"39","author":"Kahlmeter","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2019.06.015_bib0017","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00355-19","article-title":"The microbiology of bloodstream infection: 20-year trends from the SENTRY antimicrobial surveillance program","volume":"63","author":"Diekema","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl A","key":"10.1016\/j.ijantimicag.2019.06.015_bib0018","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/jac\/46.suppl_1.35","article-title":"Pivmecillinam in the treatment of urinary tract infections","volume":"46","author":"Nicolle","year":"2000","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919301682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919301682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:34:44Z","timestamp":1760376884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919301682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0924857919301682"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.06.015","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of antibiotic treatment guidelines for urinary tract infections in 15 European countries: Results of an online survey","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.06.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}